Prev Next

BP-C1 Oncology

BP-C1 Cancer care Unique product that clinically has proven to have both strong palliation properties as well as tumor control properties. more

BP-C2 Radiation Defence

BP-C2 incorporates immunomodulating and chelating ligand and a molybdenum, needed for detoxification. more

About us

Meabco A/S is a privately owned Danish pharmaceutical company with a development portfolio within cancer and radioprotection.

Meabco A/S is developing solutions with a strong emphasis on human wellbeing and quality of life, and with huge potential savings on the socio-economical costs.

Meabco’s patented technology platform is based on polyphenolic complexes, offering favorable anti-oxidative and immunomodulating properties.

The efficacy of drugs utilizing our technology has been seen to not only combat cancer and to protect from and heal radiation-induced injuries but also to balance the immune system, blood values, and other body functions.

MEABCO A/S  |  Richard Mortensens Vej 61  |  DK-2300 Copenhagen  |  Telephone: +45 32 46 03 70  | e-mail:
Websitet anvender cookies til at huske dine indstillinger, statistik og at målrette annoncer. Når du besøger vores hjemmeside, accepterer du automatisk vores brug af Cookies.